Eagle Pharmaceuticals
在场
是其中之一......
Eagle Pharmaceuticals 是一家在股票代码 EGRX (US) 下上市的公司。
涉及Eagle Pharmaceuticals的并购和融资。
- Revelation Pharma has announced the acquisition of Eagle Pharmaceuticals (公布2023七月24号).
高管
查看带有其 8 名主要高管的组织结构图
Eagle Pharmaceuticals 搜索最多的简介
- Michael Graves, Interim Executive Chairman of the Board
- Robert Glenning, Director
- Richard Edlin, Director
高管在Eagle Pharmaceuticals变化
- Steven Ratoff 曾任 Non-Executive Director, 现升职为 Non-Executive Director and Interim Chief Financial Officer (新闻发布的2024三月11号).
- Brian Cahill, Chief Financial Officer, 已经离开公司 (新闻发布的2024三月11号).
- Scott Tarriff, President, Chief Executive Officer and Director, 已经离开公司 (新闻发布的2023十一月29号).
创建提醒
跟踪 Eagle Pharmaceuticals 的高管变动
药店
Eagle Pharmaceuticals 拥有 1,868 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。
Popular M&A news in 药店
- AstraZeneca has announced the acquisition of Fusion Pharma (公布2024三月23号).
- AstraZeneca has announced the acquisition of Amolyt Pharma (公布2024三月19号).
- Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).
药店 行业的其他推荐联系人
消息
Eagle Pharmaceuticals 的最新新闻稿
- Eagle Pharmaceuticals’ Japanese Licensing Partner SymBio Announces Completion of Clinical Trial Enrollment for TREAKISYM® Rapid Infusion Liquid Bendamustine Formulation | Eagle Pharmaceuticals Investor Center
- Press Releases | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Results | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Receives Final FDA Approval for PEMFEXY™ (Pemetrexed for Injection) | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’s Disease in Collaboration With University of Pennsylvania | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals Resubmits NDA for RYANODEX for Exertional Heat Stroke | Eagle Pharmaceuticals Investor Center
- Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration to Advance Innovative Oral SM-88 for the Treatment of Patients with Cancer | Eagle Pharmaceuticals Investor Center
- Eagle Pharmaceuticals and NorthShore University HealthSystem to Study Dantrolene Sodium for the Treatment of Concussion and Other Forms of Traumatic Brain Injury | Eagle Pharmaceuticals Investor Center
- Press Releases | Eagle Pharmaceuticals Investor Center
- View more press releases Close
通过电子邮件
